ARCHIVES

Jury Awards $14 Million To Medenica Patient

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

ACS Reorganization Plans, Policy Changes Discussed By Board

November 29, 1991

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987